Menlo Park, CA, United States of America

Leland F Wilson

This inventor holds 18 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vivus, Inc., Asivi, LLC. Active years: 1999-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leland F Wilson. Retrieved from https://idiyas.com/inventor/leland-f-wilson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 23)

% Patents Active = 94.4

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 1,142(Granted Patents)

Company Filing History:

Years Active: 1999-2015

Loading Chart...

Areas of Expertise:

Topiramate

Phentermine

Weight Loss

Obesity

Pulmonary Hypertension

Sexual Dysfunction

Antidepressants

Prostaglandin

Androgenic Agent

Phosphodiesterase Inhibitors

Collagen Deposition

Vasoactive Intestinal Polypeptide

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9011906 - Escalating dosing regimen for effecting weight loss and treating obesity (2015-04-21),

2. 9011905 - Low dose topiramate/phentermine composition and methods of use thereof (2015-04-21),

3. 8895058 - Low dose topiramate/phentermine composition and methods of use thereof (2014-11-25),

4. 8895057 - Escalating dosing regimen for effecting weight loss and treating obesity (2014-11-25),

5. 8580299 - Escalating dosing regimen for effecting weight loss and treating obesity (2013-11-12),

6. 8580298 - Low dose topiramate/phentermine composition and methods of use thereof (2013-11-12),

7. 8536138 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2013-09-17),

8. 8071557 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2011-12-06),

9. 7226910 - Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists (2007-06-05),

10. 6946141 - As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation (2005-09-20),

11. 6593313 - Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction (2003-07-15),

12. 6495154 - On demand administration of clomipramine and salts thereof to treat premature ejaculation (2002-12-17),

13. 6472434 - Method for minimizing excess collagen deposition (2002-10-29),

14. 6469016 - Treatment of female sexual dysfunction using phosphodiesterase inhibitors (2002-10-22),

15. 6403597 - Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation (2002-06-11),

Title: The Innovative Journey of Leland F Wilson

Introduction: Leland F Wilson, a distinguished inventor based in Menlo Park, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Leland F Wilson's latest patents include a cutting-edge software application for data encryption and a revolutionary design for solar-powered devices.

Career Highlights: With a career spanning over two decades, Leland F Wilson has established himself as a visionary inventor with a keen eye for technological advancements. He has worked with leading tech companies to bring his ideas to life and has been recognized with multiple awards for his innovative work.

Collaborations: Throughout his career, Leland F Wilson has collaborated with top researchers, engineers, and designers to develop cutting-edge solutions in various industries. His collaborative spirit and passion for innovation have led to the successful implementation of several groundbreaking projects.

Conclusion: Leland F Wilson's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field of inventing. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.